Iberdomide (CC220)

Iberdomide (CC-220) is a novel oral immunomodulatory compound that targets cereblon, part of the CRL4CRBN E3 ubiquitin ligase complex, with an IC50 of 60 nM in a competitive TR-FRET assay. Iberdomide (CC-220) induces apoptosis with antitumor and immunostimulatory activities.
Supplier Selleck Chemicals
Product # S8760
Sku # S8760-10mM/1mL
Pricing 10mM/1mL, $197.00

Citations for this product:

Feedback